» Articles » PMID: 15046979

Crystal Structure of a Dimeric Oxidized Form of Human Peroxiredoxin 5

Overview
Journal J Mol Biol
Publisher Elsevier
Date 2004 Mar 30
PMID 15046979
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Peroxiredoxin 5 is the last discovered mammalian member of an ubiquitous family of peroxidases widely distributed among prokaryotes and eukaryotes. Mammalian peroxiredoxin 5 has been recently classified as an atypical 2-Cys peroxiredoxin due to the presence of a conserved peroxidatic N-terminal cysteine (Cys47) and an unconserved resolving C-terminal cysteine residue (Cys151) forming an intramolecular disulfide intermediate in the oxidized enzyme. We have recently reported the crystal structure of human peroxiredoxin 5 in its reduced form. Here, a new crystal form of human peroxiredoxin 5 is described at 2.0 A resolution. The asymmetric unit contains three polypeptide chains. Surprisingly, beside two reduced chains, the third one is oxidized although the enzyme was crystallized under initial reducing conditions in the presence of 1 mM 1,4-dithio-dl-threitol. The oxidized polypeptide chain forms an homodimer with a symmetry-related one through intermolecular disulfide bonds between Cys47 and Cys151. The formation of these disulfide bonds is accompanied by the partial unwinding of the N-terminal parts of the alpha2 helix, which, in the reduced form, contains the peroxidatic Cys47 and the alpha6 helix, which is sequentially close to the resolving residue Cys151. In each monomer of the oxidized chain, the C-terminal part including the alpha6 helix is completely reorganized and is isolated from the rest of the protein on an extended arm. In the oxidized dimer, the arm belonging to the first monomer now appears at the surface of the second subunit and vice versa.

Citing Articles

Unveiling the therapeutic potential of leaves: Exploring antioxidant, anti-inflammatory, anti-arthritic, and cytotoxic activities through biological and molecular docking evaluation with DFT analysis.

Sazzad N, Fahad F, Sakib S, Tayab M, Hanif M, Reza A Heliyon. 2024; 10(19):e38541.

PMID: 39403519 PMC: 11471479. DOI: 10.1016/j.heliyon.2024.e38541.


Biophysical tools to study the oligomerization dynamics of Prx1-class peroxiredoxins.

Villar S, Moller M, Denicola A Biophys Rev. 2023; 15(4):601-609.

PMID: 37681093 PMC: 10480382. DOI: 10.1007/s12551-023-01076-3.


Exploring functional and structural features of chemically related natural prenylated hydroquinone and benzoic acid from Piper crassinervium (Piperaceae) on bacterial peroxiredoxin inhibition.

Montanhero Cabrera V, do Nascimento Sividanes G, Quintiliano N, Toyama M, Lago J, de Oliveira M PLoS One. 2023; 18(2):e0281322.

PMID: 36827425 PMC: 9956870. DOI: 10.1371/journal.pone.0281322.


The Role of Peroxiredoxins in the Regulation of Sepsis.

Aki T, Unuma K, Uemura K Antioxidants (Basel). 2022; 11(1).

PMID: 35052630 PMC: 8773135. DOI: 10.3390/antiox11010126.


Oxidative Crosslinking of Peptides and Proteins: Mechanisms of Formation, Detection, Characterization and Quantification.

Fuentes-Lemus E, Hagglund P, Lopez-Alarcon C, Davies M Molecules. 2022; 27(1).

PMID: 35011250 PMC: 8746199. DOI: 10.3390/molecules27010015.